1. Paediatric Phase I-II Clinical Trials Unit, Paediatric Haematology & Oncology, Hospital Niño Jesus, Madrid, Spain
2. Instituto de Investigación Sanitaria La Princesa, Madrid, Spain
3. Paediatric Drug Development, Children and Young People’s Unit, Royal Marsden Hospital, London, UK
4. Emma Children’s Hospital, Amsterdam, Netherlands
5. Hoffman-La Roche, Basel, Switzerland
6. Department of Paediatric and Adolescent Oncology, Institut Gustave Roussy, Villejuif, France
7. Department of Pediatric Oncology and Hematology, Charite University Hospital, Berlin, Germany
8. Department of Paediatric, Adolescents and Young Adults Oncology and INSERM U830, Institut Curie, Paris, France
9. Department Paediatric Oncology, Great Ormond Street Hospital, London, UK
10. Division of Clinical Studies, Institute of Cancer Research, London, UK
11. Centre for Medical Genetic, Ghent University, Ghent, Belgium
12. Princess Maxima Center for Pediatric Oncology, University of Amsterdam, Amsterdam, Netherlands
13. Department of Pediatric Oncology, University of Essen, Essen, Germany
14. Theodor Boveri Institute and Comprehensive Cancer Center Mainfranken, Biocenter, University of Wurzburg, Wurzburg, Germany
15. Department of Women's and Children’s Health, Karolinska Institute, Stockholm, Sweden
16. School of Biosciences, University of Kent, Canterbury, UK
17. Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle, UK
18. Department of Pediatric Oncology and Hematology, University of Cologne, Cologne, Germany
19. European Medicines Agency, London, UK
20. Masaryk University, University Hospital, Brno, Czech Republic
21. Department of Pediatric Oncology, International Clinical Research Center, St. Anne’s University Hospital, Brno, Czech Republic
22. RECAMO, Masaryk Memorial Cancer Centre, Brno, Czech Republic
23. Pediatric Hematology/Oncology Unit, Antwerp University Hospital, Antwerp, Belgium
24. Department of Clinical Research, Gustave Roussy, Paris-Sud University, Paris, France